RESPONSE AFTER NON-FINAL ACTION - ENTERED
final action
on 06 Jan 2025
Last Applicant/ Owned by
345 PARK AVENUE SOUTH
NEW YORK
NY
10010
Serial Number
98301402 filed on 06th Dec 2023
Registration Number
N/A
Correspondent Address
J. Dickson Phillips III
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
ELION THERAPEUTICS
Pharmaceutical research and development; Research and development of medications administered by a healthcare professional in a healthcare setting for systemic fungal infections or invasive fungal disease; Providing scientific information on the disease state and treatment of invasive fungal infections and invasive fungal disease; Providing a website featuring scientific information about the dis Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Pharmaceutical research and development; Research and development of medications administered by a healthcare professional in a healthcare setting for systemic fungal infections or invasive fungal disease; Providing scientific information on the disease state and treatment of invasive fungal infections and invasive fungal disease; Providing a website featuring scientific information about the disease state and treatment of invasive fungal infections and invasive fungal disease
First Use Date in General
10th Jan 2024
First Use Date in Commerce
10th Jan 2024
Mark Details
Serial Number
No 98301402
Mark Type
No Service Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 06th Jan 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 06th Jan 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 06th Jan 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 03rd Sep 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| 03rd Sep 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| 05th Jul 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 05th Jul 2024 | USE AMENDMENT ACCEPTED |
| 05th Jul 2024 | ASSIGNED TO EXAMINER |
| 05th Jul 2024 | NON-FINAL ACTION E-MAILED |
| 05th Jul 2024 | NON-FINAL ACTION WRITTEN |